Anti‐PD‐L1 alone and in combination with RT significantly increased the CD8/Treg ratio, an important metric of anti‐tumor response to treatment (Byrne et al, 2011; Amedei et al, 2013; Diana et al, 2016a). Here, CD8A is linked to neoplasm.